Literature DB >> 19907969

Human embryo culture and assessment for the derivation of embryonic stem cells (ESC).

A Henry Sathananthan1, Tiki Osianlis.   

Abstract

The culture and critical assessment of early human embryos during the first week of human development are reviewed for the derivation of ESC. Both normal and abnormal features are assessed by phase contrast microscopy of whole embryos and in serial sections of fixed material by light and electron microscopy (TEM). Normal embryos follow a time table of development and have equal blastomeres with minimal fragmentation and nuclear defects. Abnormal embryos show more fragmentation and nuclear aberrations such as micronucleation and multinucleation, reflected by aneuploidy, polyploidy, and mosaicism. The selection of normal embryos and the hardiest of embryos that survive to blastocysts is recommended for the derivation and culture of ESC.

Entities:  

Mesh:

Year:  2010        PMID: 19907969     DOI: 10.1007/978-1-60761-369-5_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Single-cell DNA methylome sequencing of human preimplantation embryos.

Authors:  Ping Zhu; Hongshan Guo; Yixin Ren; Yu Hou; Ji Dong; Rong Li; Ying Lian; Xiaoying Fan; Boqiang Hu; Yun Gao; Xiaoye Wang; Yuan Wei; Ping Liu; Jie Yan; Xiulian Ren; Peng Yuan; Yifeng Yuan; Zhiqiang Yan; Lu Wen; Liying Yan; Jie Qiao; Fuchou Tang
Journal:  Nat Genet       Date:  2017-12-18       Impact factor: 38.330

Review 2.  Human pre-implantation embryo development.

Authors:  Kathy K Niakan; Jinnuo Han; Roger A Pedersen; Carlos Simon; Renee A Reijo Pera
Journal:  Development       Date:  2012-03       Impact factor: 6.868

3.  5-Formylcytosine landscapes of human preimplantation embryos at single-cell resolution.

Authors:  Yun Gao; Lin Li; Peng Yuan; Fan Zhai; Yixin Ren; Liying Yan; Rong Li; Ying Lian; Xiaohui Zhu; Xinglong Wu; Kehkooi Kee; Lu Wen; Jie Qiao; Fuchou Tang
Journal:  PLoS Biol       Date:  2020-07-30       Impact factor: 8.029

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.